Concepedia

Jonathan Back

JB

Statistics

Publications

17

Citations

1.2K

H-Index

15

Active since

2002

Affiliations

Glenmark Pharmaceuticals (Switzerland)(Current)

University of Lausanne

Ludwig Cancer Research

Inserm

Centre National de la Recherche Scientifique

Jonathan Back is an author at Glenmark Pharmaceuticals (Switzerland) specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

2002–2019

17

Publications

17

Long-term, multilineage hematopoiesis occurs in the combined absence of β-catenin and γ-catenin

Grégoire Jeannet, Marina Scheller, Léonardo Scarpellino et al. · Blood · 2007 · 213 citations · Full text

GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis

Emma Guttman‐Yassky, Ana B. Pavel, Lisa Zhou et al. · Journal of Allergy and Clinical Immunology · 2019 · 210 citations · Full text

A Role for cis Interaction between the Inhibitory Ly49A Receptor and MHC Class I for Natural Killer Cell Education

Anick Chalifour, Léonardo Scarpellino, Jonathan Back et al. · Immunity · 2009 · 134 citations · Full text

, , +12

PU.1 determines the self-renewal capacity of erythroid progenitor cells

Jonathan Back, Andrée Dierich, Corinne Bronn et al. · Blood · 2004 · 118 citations · Full text

Enhanced bone formation in lipodystrophic PPARγ <sup> <i>hyp/hyp</i> </sup> mice relocates haematopoiesis to the spleen

Terrie‐Anne Cock, Jonathan Back, Florent Elefteriou et al. · EMBO Reports · 2004 · 118 citations · Full text

1–5 of 17